4.6 Article

Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [18F]-FEPPA

Journal

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 32, Issue 6, Pages 968-972

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jcbfm.2012.46

Keywords

genetics; inflammation; microglia; mitochondria; positron emission tomography

Funding

  1. Canada Foundation for Innovation
  2. Ontario Ministry of Research and Innovation
  3. Scottish Grant Charitable Foundation
  4. CIHR
  5. Ontario Mental Health Foundation

Ask authors/readers for more resources

[F-18]-FEPPA binds to the 18-kDa translocator protein (TSPO) and is used in positron emission tomography (PET) to detect microglial activation. However, quantitative interpretations of the PET signal with new generation TSPO PET radioligands are confounded by large interindividual variability in binding affinity. This presents as a trimodal distribution, reflecting high-affinity binders (HABs), low-affinity binder (LAB), and mixed-affinity binders (MABs). Here, we show that one polymorphism (rs6971) located in exon 4 of the TSPO gene, which results in a nonconservative amino-acid substitution from alanine to threonine (Ala147Thr) in the TSPO protein, predicts [F-18]-FEPPA total distribution volume in human brains. In addition, [F-18]-FEPPA exhibits clearly different features in the shape of the time activity curves between genetic groups. Testing for the rs6971 polymorphism may allow quantitative interpretation of TSPO PET studies with new generation of TSPO PET radioligands. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 968-972; doi:10.1038/jcbfm.2012.46; published online 4 April 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available